246 related articles for article (PubMed ID: 16958942)
1. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study.
Sato S; Yamakawa Y; Terashima Y; Ohta H; Asada T
Psychiatry Clin Neurosci; 2006 Oct; 60(5):584-9. PubMed ID: 16958942
[TBL] [Abstract][Full Text] [Related]
2. Mood disorders after stroke: diagnostic validation of the poststroke depression rating scale.
Quaranta D; Marra C; Gainotti G
Cerebrovasc Dis; 2008; 26(3):237-43. PubMed ID: 18648195
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression.
Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH
Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655
[TBL] [Abstract][Full Text] [Related]
4. Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness.
Spalletta G; Guida G; De Angelis D; Caltagirone C
J Neurol; 2002 Nov; 249(11):1541-51. PubMed ID: 12420095
[TBL] [Abstract][Full Text] [Related]
5. Emotional withdrawal, CT abnormalities and drug response in late life depression.
Altamura AC; Bassetti R; Santini A; Frisoni GB; Mundo E
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):349-54. PubMed ID: 14751432
[TBL] [Abstract][Full Text] [Related]
6. Is poststroke depression a major depression?
da Rocha e Silva CE; Alves Brasil MA; Matos do Nascimento E; de Bragança Pereira B; André C
Cerebrovasc Dis; 2013; 35(4):385-91. PubMed ID: 23635428
[TBL] [Abstract][Full Text] [Related]
7. Resolution of sexual dysfunction during acute treatment of major depression with milnacipran.
Baldwin D; Moreno RA; Briley M
Hum Psychopharmacol; 2008 Aug; 23(6):527-32. PubMed ID: 18536065
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach.
de Coster L; Leentjens AF; Lodder J; Verhey FR
Int J Geriatr Psychiatry; 2005 Apr; 20(4):358-62. PubMed ID: 15799083
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of milnacipran on poststroke depression on inpatient rehabilitation.
Yamakawa Y; Satoh S; Sawa S; Ohta H; Asada T
Psychiatry Clin Neurosci; 2005 Dec; 59(6):705-10. PubMed ID: 16401247
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture.
Lenze EJ; Munin MC; Dew MA; Rogers JC; Seligman K; Mulsant BH; Reynolds CF
Int J Geriatr Psychiatry; 2004 May; 19(5):472-8. PubMed ID: 15156549
[TBL] [Abstract][Full Text] [Related]
11. Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis.
Mandelli L; Serretti A; Colombo C; Florita M; Santoro A; Rossini D; Zanardi R; Smeraldi E
Psychiatry Clin Neurosci; 2006 Oct; 60(5):598-604. PubMed ID: 16958944
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
Lopez-Ibor JJ; Conesa A;
Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743
[TBL] [Abstract][Full Text] [Related]
13. No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disorders.
Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N
Psychiatry Clin Neurosci; 2008 Apr; 62(2):197-202. PubMed ID: 18412843
[TBL] [Abstract][Full Text] [Related]
14. Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics.
Nys GM; van Zandvoort MJ; van der Worp HB; de Haan EH; de Kort PL; Kappelle LJ
J Neurol Sci; 2005 Jan; 228(1):27-33. PubMed ID: 15607207
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease.
Mizukami K; Hatanaka K; Tanaka Y; Sato S; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):349-52. PubMed ID: 19166899
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients.
Naito S; Sato K; Yoshida K; Higuchi H; Takahashi H; Kamata M; Ito K; Ohkubo T; Shimizu T
Psychiatry Clin Neurosci; 2007 Aug; 61(4):421-7. PubMed ID: 17610668
[TBL] [Abstract][Full Text] [Related]
17. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis.
Chen Y; Guo JJ; Zhan S; Patel NC
Ann Pharmacother; 2006 Dec; 40(12):2115-22. PubMed ID: 17119102
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on depressive state following stroke].
Kikumoto O
Seishin Shinkeigaku Zasshi; 1990; 92(7):411-34. PubMed ID: 2236345
[TBL] [Abstract][Full Text] [Related]
19. The Post-Stroke Depression Rating Scale: a test specifically devised to investigate affective disorders of stroke patients.
Gainotti G; Azzoni A; Razzano C; Lanzillotta M; Marra C; Gasparini F
J Clin Exp Neuropsychol; 1997 Jun; 19(3):340-56. PubMed ID: 9268809
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study.
Rampello L; Alvano A; Chiechio S; Raffaele R; Vecchio I; Malaguarnera M
Arch Gerontol Geriatr; 2005; 40(3):275-85. PubMed ID: 15814161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
